Xác định các gen biểu hiện khác biệt methyl hóa chính trong ependymoma hố sau dựa trên phân tích epigenome và transcriptome

Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 2015;17(Suppl 4):v1–62. Gerstner ER, Pajtler KW. Ependymoma. Semin Neurol. 2018;38(1):104–11. Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell. 2015;27(5):728–43. Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stutz AM, et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature. 2014;506(7489):445–50. Panwalkar P, Clark J, Ramaswamy V, Hawes D, Yang F, Dunham C, et al. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome. Acta Neuropathol. 2017;134(5):705–14. Bayliss J, Mukherjee P, Lu C, Jain SU, Chung C, Martinez D, et al. Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas. Sci Transl Med. 2016;8(366):161r–366r. Jain SU, Do TJ, Lund PJ, Rashoff AQ, Diehl KL, Cieslik M, et al. PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism. Nat Commun. 2019;10(1):2146. Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell. 2011;20(2):143–57. Wongtrakoongate P. Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries. World J Stem Cells. 2015;7(1):137–48. Sandberg DI, Yu B, Patel R, Hagan J, Miesner E, Sabin J, et al. Infusion of 5-Azacytidine (5-AZA) into the fourth ventricle or resection cavity in children with recurrent posterior Fossa Ependymoma: a pilot clinical trial. J Neurooncol. 2019;141(2):449–57. Rahman R, Osteso-Ibanez T, Hirst RA, Levesley J, Kilday JP, Quinn S, et al. Histone deacetylase inhibition attenuates cell growth with associated telomerase inhibition in high-grade childhood brain tumor cells. Mol Cancer Ther. 2010;9(9):2568–81. Rogers HA, Chapman R, Kings H, Allard J, Barron-Hastings J, Pajtler KW, et al. Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma. Oncotarget. 2018;9(92):36530–41. Griesinger AM, Josephson RJ, Donson AM, Mulcahy LJ, Amani V, Birks DK, et al. Interleukin-6/STAT3 pathway signaling drives an inflammatory phenotype in Group A ependymoma. Cancer Immunol Res. 2015;3(10):1165–74. Fukuoka K, Kanemura Y, Shofuda T, Fukushima S, Yamashita S, Narushima D, et al. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors. Acta Neuropathol Commun. 2018;6(1):134. Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, et al. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis. J Clin Oncol. 2016;34(21):2468–77. Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. Botia JA, Vandrovcova J, Forabosco P, Guelfi S, D’Sa K, Hardy J, et al. An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks. Bmc Syst Biol. 2017;11(1):47. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL. Hierarchical organization of modularity in metabolic networks. Science. 2002;297(5586):1551–5. Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782–95. Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. Ellison DW, Aldape KD, Capper D, Fouladi M, Gilbert MR, Gilbertson RJ, et al. cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors. BRAIN Pathol. 2020;30(5):863–6. Zhang MW, Fujiwara K, Che X, Zheng S, Zheng L. DNA methylation in the tumor microenvironment. J Zhejiang Univ Sci B. 2017;18(5):365–72. Gumz ML, Lynch IJ, Greenlee MM, Cain BD, Wingo CS. The renal H+-K+-ATPases: physiology, regulation, and structure. Am J Physiol Renal Physiol. 2010;298(1):F12–21. Wang G, Hu N, Yang HH, Wang L, Su H, Wang C, et al. Comparison of global gene expression of gastric cardia and noncardia cancers from a high-risk population in china. PLoS ONE. 2013;8(5):e63826. Yan Z, Luke BT, Tsang SX, Xing R, Pan Y, Liu Y, et al. Identification of gene signatures used to recognize biological characteristics of gastric cancer upon gene expression data. Biomark Insights. 2014;9:67–76. Wang W, He Y, Zhao Q, Zhao X, Li Z. Identification of potential key genes in gastric cancer using bioinformatics analysis. Biomed Rep. 2020;12(4):178–92. Ray AM, Zunic A, Alten RL, McElfresh JS, Hanks LM, Millar JG. Cis-Vaccenyl acetate, a female-produced sex pheromone component of Ortholeptura valida, a longhorned beetle in the subfamily Lepturinae. J Chem Ecol. 2011;37(2):173–8. Shao RX, Hoshida Y, Otsuka M, Kato N, Tateishi R, Teratani T, et al. Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients. World J Gastroenterol. 2005;11(13):1995–9. McCormick CA, Samuels TL, Battle MA, Frolkis T, Blumin JH, Bock JM, et al. H+/K+ATPase expression in the larynx of laryngopharyngeal reflux and laryngeal cancer patients. Laryngoscope. 2020;131(1):130–5. Lin S, Lin B, Wang X, Pan Y, Xu Q, He JS, et al. Silencing of ATP4B of ATPase H(+)/K(+) transporting beta subunit by intragenic epigenetic alteration in human gastric cancer cells. Oncol Res. 2017;25(3):317–29. Ching KH, Burbelo PD, Carlson PJ, Drevets WC, Iadarola MJ. High levels of Anti-GAD65 and Anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbance. J Neuroimmunol. 2010;222(1–2):87–9. Hjeij R, Onoufriadis A, Watson CM, Slagle CE, Klena NT, Dougherty GW, et al. CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation. AM J Hum Genet. 2014;95(3):257–74. Alsaadi MM, Erzurumluoglu AM, Rodriguez S, Guthrie PA, Gaunt TR, Omar HZ, et al. Nonsense mutation in coiled-coil domain containing 151 gene (CCDC151) causes primary ciliary dyskinesia. Hum Mutat. 2014;35(12):1446–8. Zhang W, Li D, Wei S, Guo T, Wang J, Luo H, et al. Whole-exome sequencing identifies a novel CCDC151 mutation, c.325G>T (p.E109X), in a patient with primary ciliary dyskinesia and situs inversus. J Hum Genet. 2019;64(3):249–52. Mitchison HM, Valente EM. Motile and non-motile cilia in human pathology: from function to phenotypes. J Pathol. 2017;241(2):294–309. Bustamante-Marin XM, Ostrowski LE. Cilia and mucociliary clearance. Csh Perspect Biol. 2017;9(4):a028241. Chiani F, Orsini T, Gambadoro A, Pasquini M, Putti S, Cirilli M, et al. Functional loss of Ccdc1 51 leads to hydrocephalus in a mouse model of primary ciliary dyskinesia. Dis Model Mech. 2019;12(8):dmm038489. Naso MF, et al. Dermokine: an extensively differentially spliced gene expressed in epithelial cells. J Invest Dermatol. 2007;127(7):1622–31. Leclerc EA, Huchenq A, Kezic S, Serre G, Jonca N. Mice deficient for the epidermal dermokine beta and gamma isoforms display transient cornification defects. J Cell Sci. 2014;127(Pt 13):2862–72. Huang C, Xiang Y, Chen S, Yu H, Wen Z, Ye T, et al. Dermokine contributes to epithelial-mesenchymal transition through increased activation of signal transducer and activator of transcription 3 in pancreatic cancer. Cancer Sci. 2017;108(11):2130–41. Morris AR, Bos A, Diosdado B, Rooijers K, Elkon R, Bolijn AS, et al. Alternative cleavage and polyadenylation during colorectal cancer development. Clin Cancer Res. 2012;18(19):5256–66. Xiong H, Yang Q, Zhang X, Wang P, Chen F, Liu Y, et al. Significant association of rare variant p.Gly8Ser in cardiac sodium channel beta4-subunit SCN4B with atrial fibrillation. Ann Hum Genet. 2019;83(4):239–48. Yang Q, Xiong H, Xu C, Huang Y, Tu X, Wu G, et al. Identification of rare variants in cardiac sodium channel beta4-subunit gene SCN4B associated with ventricular tachycardia. Mol Genet Genomics. 2019;294(4):1059–71. Bigan E, Sasidharan NS, Lejeune FX, Fragnaud H, Parmentier F, Megret L, et al. Genetic cooperativity in multi-layer networks implicates cell survival and senescence in the striatum of Huntington’s disease mice synchronous to symptoms. Bioinformatics. 2020;36(1):186–96. Bon E, Driffort V, Gradek F, Martinez-Caceres C, Anchelin M, Pelegrin P, et al. SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancer. Nat Commun. 2016;7:13648. Marin M, Esteban FJ, Ramirez-Rodrigo H, Ros E, Saez-Lara MJ. An integrative methodology based on protein-protein interaction networks for identification and functional annotation of disease-relevant genes applied to channelopathies. BMC Bioinformatics. 2019;20(1):565. Zhang T, Wu DM, Deng SH, Han R, Liu T, Li J, et al. Integrated analysis reveals that long non-coding RNA TUBA4B can be used as a prognostic biomarker in various cancers. Cell Physiol Biochem. 2018;49(2):530–44. Rodrigues JC, Gonzalez GC, Zhang L, Ibrahim G, Kelly JJ, Gustafson MP, et al. Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol. 2010;12(4):351–65. Su YT, Butler M, Zhang M, Zhang W, Song H, Hwang L, et al. MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment. Neurooncol Adv. 2020;2(1):a65. Yang T, Kong Z, Ma W. PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential. Hum Vaccin Immunother. 2020;17:1–8. Alban TJ, Bayik D, Otvos B, Rabljenovic A, Leng L, Jia-Shiun L, et al. Glioblastoma myeloid-derived suppressor cell subsets express differential macrophage migration inhibitory factor receptor profiles that can be targeted to reduce immune suppression. Front Immunol. 2020;11:1191. Nambirajan A, Malgulwar PB, Sharma A, Boorgula MT, Doddamani R, Singh M, Suri V, Sarkar C, Sharma MC. Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade? Brain Tumor Pathol. 2019;36(4):152–61. Hoffman LM, Donson AM, Nakachi I, Griesinger AM, Birks DK, Amani V, et al. Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma. Acta Neuropathol. 2014;127(5):731–45. Michealraj KA, Kumar SA, Kim L, Cavalli F, Przelicki D, Wojcik JB, et al. Metabolic regulation of the epigenome drives lethal infantile ependymoma. Cell. 2020;181(6):1329–45. Filippi I, Carraro F, Naldini A. Interleukin-1beta affects MDAMB231 breast cancer cell migration under hypoxia: role of HIF-1alpha and NFkappaB transcription factors. Mediators Inflamm. 2015;2015:789414. Ahn KS, Sethi G, Aggarwal BB. Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway. Biochem Pharmacol. 2008;75(4):907–13.